Gold tier: mechanically validated evidence, with its primary source.
709 evidence items · page 10 / 29
5 per_person_yearMorbidity among people living with HIV/AIDS during the first year of antiretroviral therapy implementation was 5–10% per person-year.
Côte d'IvoireVIH/sidapublished 2009Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument of 5 observations
29 %Symptomatic infections accounted for 29% of all malaria-positive individuals.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
1 %The Cameroun haplotype was detected in 1% of samples.
Côte d'Ivoirehemoglobinobserved 2022HAL · Unilimdocument of 23 observations
16.97 yearsDiscounted life expectancy was 16.97 years with viral load confirmation of immunologic failure.
Côte d'IvoireVIH/sidapublished 2016Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 5 observations
112 patients112 out of 491 adult HIV patients had CD4+ T-cell count less than 200/mm³.
Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
10.8 %HBsAg positivity prevalence among first-time blood donors in Abidjan remained stable at 10.8% in 1992–1994 and 11.1% in 2010–2012.
Côte d'Ivoirehépatite Bobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
53 yearsThe median age of the 95 HIV-2 patients in the cohort was 53 years, with an interquartile range of 47–60 years.
Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations
56.5 %The Benin haplotype was detected in 56.5% of samples.
Côte d'Ivoirehemoglobinobserved 2022HAL · Unilimdocument of 23 observations
51.2 %En Côte d’Ivoire, les taux de survie à trois ans des femmes atteintes d’un cancer du sein sont de 51,2 %.
Côte d'Ivoirecancer du seinHAL · Unilimdocument of 81 observations
34 %Among HIV-infected adults interviewed, 34% were in a stable partnership with a partner whose HIV serostatus they were not aware of.
Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations
43 %43% of the patients were initially classified as HIV-1&2 dually reactive.
Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations
97.7 %97.7% of 86 antiretroviral-naïve HIV-HBV co-infected patients from Côte d'Ivoire harboured HBV genotype E at ARV-initiation.
Côte d'Ivoirehépatite Bpublished 2018Journal of viral hepatitiseurope_pmcdocument of 7 observationsDOI 10.1111/jvh.12914
78 %Four hundred seventy-seven patients included 78% women.
Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations
74 casesAmong the 128 cases of non-occupational HIV exposure, 74 were due to rape.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
5.53 aHRUrine LAM positivity was independently associated with mortality (aHR = 5.53, 95% CI, 1.09–28.06, p = .0389).
Côte d'Ivoiretuberculosepublished 2025BMC infectious diseaseseurope_pmcdocument of 9 observations
20.2 %Cerebral toxoplasmosis accounted for 20.2% of causes of death.
Côte d'Ivoirecerebral toxoplasmosispublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations
57 %57% of the patients were initially classified as HIV-2.
Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations
Combined results of the three cross-sectional surveys showed mean prevalence rates ranging from 10.9% to 33%.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
464 /mm3Among the 2056 patients, median CD4 count was 464/mm3 at baseline.
Côte d'IvoireVIH/sidapublished 2017PloS oneeurope_pmcdocument of 8 observations
93.6 %Most patients were infected with HIV1 (93.6%).
Côte d'IvoireHIV1published 2010Le Mali medicaleurope_pmcdocument of 17 observations
33.8 %Among children aged 0–4 years, malaria prevalence was 33.8%.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
79 %In the per-protocol analysis, HIV RNA less than 50 copies/ml at 24 weeks was observed in 23 of 29 (79%) patients in the ZDV arm.
Côte d'IvoireVIH/sidapublished 2017AIDS (London, England)europe_pmcdocument of 7 observations
0.87 per_100_person_monthsDuring the post-intervention period, the crude incidence rates were 0.87 cases per 100 person-months in the LLIN-alone control group.
Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations
-118.4 per_weekThe volume of HIV viral load tests performed decreased by 118.4 tests per week in Côte d'Ivoire after the beginning of the pandemic.
Côte d'IvoireVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations
30.3 %Among 66 HBsAg-positive patients, 30.3% had HBeAg-negative hepatitis.
Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.